Two new macrocyclic ligands 1,4,7,9,12-pentaaza-10,11-dioxo-8,9,12,13-bis-(1-oxo-3-thio-2-hydropyrimidine)-trideca-7,13-diene, (L
1) and 1,4,7,9,12-pentaaza-10,12-dioxo-8,9,13,14-bis-(1-oxo-3-thio-2-hydropyrimidine)-tetradeca-7,14-diene, (L
2) and their complexes with Cr
III, Mn
II, Fe
III, Co
II, Ni
II, Cu
II and Zn
II have been synthesized, and characterized by elemental analysis, i.r.,
1H-n.m.r., e.p.r., u.v.–vis. spectroscopy, magnetic susceptibility and conductance measurements. The conductivity measurements suggest that the complexes of divalent metal ions are 1:1 electrolytes whereas the trivalent metal ions are non-electrolytes. On the basis of electronic spectra and magnetic moment measurements the Cr
III and Fe
III complexes are octahedral, while the divalent metal complexes are tetrahedral except for the Ni
II and Cu
II complexes which are proposed to have square planar geometry. All the ligands and their complexes have been screened against gram-positive bacteria
Staphylococcus aureus and gram-negative bacteria
E. coli. The results show that they inhibit the growth of bacteria.
相似文献